Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of AJG511 (budesonide) in active ulcerative colitis
jRCT2080222245Phase 2
- Sponsor
- Ajinomoto
- Start
- Oct 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of budesonide in autoimmune colitis, sponsored by Ajinomoto.
02
Drugs
budesonide
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on jRCT2080222245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222245.